UK markets closed

Revelation Biosciences, Inc. (REVB)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
2.2650-0.0550 (-2.37%)
As of 02:43PM EDT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
Total revenue
0
0
0
0
Operating expenses
Research development
7,703
4,146
5,377
6,915
Selling general and administrative
5,800
4,511
5,487
5,036
Total operating expenses
13,503
8,657
10,865
11,950
Operating income or loss
-13,503
-8,657
-10,865
-11,950
Total other income/expenses net
8,536
8,536
34.962
-36.352
Income before tax
-13,482
-120.254
-10,830
-11,987
Income from continuing operations
-13,482
-120.254
-10,830
-11,987
Net income
-13,482
-120.254
-10,830
-11,987
Net income available to common shareholders
-13,482
-120.254
-10,830
-11,987
Basic EPS
-2.10
-
-149.20
-972.41
Diluted EPS
-2.70
-
-149.20
-972.41
Basic average shares
127.125
-
72.585
12.327
Diluted average shares
131.287
-
72.585
12.327